Technology ID
TAB-4624

Diagnostic Real-time TaqMan® PCR for Human Adenovirus Type 4

E-Numbers
E-032-2015-0
Lead Inventor
Erdman, Dean
Lead IC
CDC
Co-Inventors
Lu, Xiaoyan
ICs
CDC
Applications
Research Materials
Diagnostics
Therapeutic Areas
Infectious Disease
Development Stages
Pre-Clinical (in vitro)
Research Products
Plasmids/Vectors

This technology includes a real-time polymerase chain reaction (PCR) assay using hydrolysis probe (TaqMan®) chemistry which was developed for detection and type-specific identification of human adenovirus type 4 (HAd4) genomic DNA in clinical specimens. The assay uses unique oligonucleotide primer and probes designed to conserved regions of the HAd4 hexon protein gene. Assay reagents and amplification conditions were optimized and sensitivity and specificity characteristics determined with DNA extracts from multiple HAd4 laboratory strains and other respiratory viral pathogens.

Commercial Applications
Diagnostic test for Had4.

Competitive Advantages
Utilizes unique oligonucleotide primer and probes designed to conserved regions of the HAd4 hexon protein gene.
Licensing Contact:
Motley, Jonathan
jonathan.motley@nih.gov